SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 86 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,000 | 0.0% | 2,990 | +15.1% | 0.00% | 0.0% |
| Q2 2022 | $5,000 | 0.0% | 2,597 | +18.3% | 0.00% | 0.0% |
| Q1 2022 | $5,000 | 0.0% | 2,196 | +89.8% | 0.00% | 0.0% |
| Q4 2021 | $5,000 | +25.0% | 1,157 | +131.4% | 0.00% | 0.0% |
| Q3 2021 | $4,000 | -50.0% | 500 | -37.3% | 0.00% | 0.0% |
| Q2 2021 | $8,000 | +14.3% | 797 | -1.1% | 0.00% | -66.7% |
| Q1 2021 | $7,000 | +75.0% | 806 | +35.9% | 0.00% | +50.0% |
| Q4 2020 | $4,000 | -42.9% | 593 | 0.0% | 0.00% | -33.3% |
| Q3 2020 | $7,000 | +75.0% | 593 | 0.0% | 0.00% | +50.0% |
| Q2 2020 | $4,000 | +300.0% | 593 | +97.7% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 300 | -40.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 500 | +66.7% | 0.00% | – |
| Q1 2019 | $1,000 | – | 300 | +50.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 200 | -33.3% | 0.00% | – |
| Q3 2018 | $1,000 | -75.0% | 300 | -40.0% | 0.00% | -100.0% |
| Q2 2018 | $4,000 | +300.0% | 500 | +150.0% | 0.00% | – |
| Q1 2018 | $1,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 6,000,000 | $66,900,000 | 2.57% |
| SABBY MANAGEMENT, LLC | 606,298 | $6,760,000 | 1.01% |
| Virtus ETF Advisers LLC | 66,851 | $745,000 | 0.39% |
| Newbridge Financial Services Group, Inc. | 26,900 | $300,000 | 0.30% |
| Avidian Wealth Solutions, LLC | 330,000 | $3,680,000 | 0.28% |
| Spectrum Wealth Advisory Group, LLC | 36,692 | $422,000 | 0.27% |
| COWEN AND COMPANY, LLC | 129,200 | $1,441,000 | 0.24% |
| Cormorant Asset Management, LP | 500,000 | $5,575,000 | 0.21% |
| SYMMETRY PEAK MANAGEMENT LLC | 27,500 | $307,000 | 0.20% |
| Aristides Capital LLC | 24,302 | $271,000 | 0.19% |